{
    "Trade/Device Name(s)": [
        "GEM Premier ChemSTAT"
    ],
    "Submitter Information": "Instrumentation Laboratory Co.",
    "510(k) Number": "K183555",
    "Predicate Device Reference 510(k) Number(s)": [
        "K024098",
        "K954000",
        "K031879"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JFY",
        "CDQ",
        "KHS"
    ],
    "Summary Letter Date": "December 19, 2018",
    "Summary Letter Received Date": "December 20, 2018",
    "Submission Date": "February 11, 2019",
    "Regulation Number(s)": [
        "21 CFR 862.1225",
        "21 CFR 862.1770",
        "21 CFR 862.1160"
    ],
    "Regulation Name(s)": [
        "Creatinine test system",
        "Urea nitrogen test system",
        "Bicarbonate/carbon dioxide test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Creatinine",
        "Blood Urea Nitrogen",
        "Total Carbon Dioxide"
    ],
    "Specimen Type(s)": [
        "Lithium heparinized whole blood (arterial)",
        "Lithium heparinized whole blood (venous)"
    ],
    "Specimen Container(s)": [
        "Lithium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "GEM Premier ChemSTAT analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Enzymatic amperometry",
        "Enzymatic potentiometry",
        "Potentiometry"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer",
        "Cartridge",
        "Calibration solution"
    ],
    "Document Summary": "FDA 510(k) summary for GEM Premier ChemSTAT analyzer measuring creatinine, BUN, and tCO2 in lithium heparinized whole blood at point-of-care and clinical laboratory settings.",
    "Indications for Use Summary": "Provides quantitative measurement of creatinine, BUN, and total carbon dioxide in arterial and venous lithium heparinized whole blood to aid diagnosis of acid/base status and metabolite balance in clinical and point-of-care settings.",
    "fda_folder": "Clinical Chemistry"
}